查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553598

结构生物学和分子建模技术市场规模、份额和趋势分析报告：按工具、按应用、按地区、细分市场预测，2024-2030 年

Structural Biology & Molecular Modeling Techniques Market Size, Share & Trends Analysis Report By Tools (SaaS & Standalone Modeling), By Application (Drug Development), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

结构生物学和分子建模技术市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球结构生物学和分子建模技术市场规模将达到191.7亿美元，2024年至2030年复合年增长率为15.4%。

不健康生活方式的不断增加导致糖尿病和癌症等慢性病的盛行率急剧上升，预计这将在预测期内推动市场成长。

此外，据猜测，不断增加的抗药性和高药物消耗率正在产生对广泛研究和开发活动的需求，这正在推动结构生物学和分子建模技术在药物发现和开发过程中的采用。预计这将成为加速高效药物开发的有效方法。

对分子建模技术日益增长的需求主要是由于可以显着节省成本。这是因为预测软体可以透过在临床前阶段识别可能的副作用并确定药物疗效和毒性来降低后期药物失败的可能性。因此，上述因素是市场需求成长的重要原因。

结构生物学和分子建模技术市场报告亮点

  • 由于电脑辅助建构和建模技术在研发中的广泛使用，到 2023 年，SaaS 和独立建模在工具领域占据最大份额。
  • 由于专注于增强药物发现设计、旨在加速识别新疗法的过程的软体的不断改进，药物发现部分预计将以有利的复合年增长率增长。
  • 2023年，由于存在大量广泛参与In Silico工具商业化并促进其利用的成熟製药公司，北美主导了全球结构生物学和分子建模技术市场。
  • 由于政府积极支持研究活动以及新兴经济体研发外包的趋势不断增长，亚太地区预计将以复合年增长率大幅增长。
  • 主要参与企业正在采用临床和研究合作策略来加速结构预测软体和资料库的采用，以获得竞争优势。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章结构生物学和分子建模技术市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 结构生物学与分子建模技术市场分析工具
    • 波特的分析
    • PESTEL分析

第四章结构生物学和分子建模技术市场：工具估计和趋势分析

  • 细分仪表板
  • 结构生物学与分子建模技术市场：2023 年和 2030 年按工具进行的变异分析
  • SaaS 与独立建模
  • 视觉化和分析
  • 资料库
  • 其他的

第五章结构生物学和分子建模技术市场：按应用估算和趋势分析

  • 细分仪表板
  • 结构生物学与分子建模技术市场：2023 年和 2030 年按应用分类的变异分析
  • 药物开发
  • 药物发现
  • 其他的

第六章结构生物学和分子建模技术市场：区域估计和趋势分析

  • 2023 年和 2030 年结构生物学和分子建模技术市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Acellera Therapeutics Inc
    • Agilent Technologies, Inc
    • Labvantage-Biomax GmbH
    • Bruker
    • Chemical Computing Group ULC
    • Dassault Systemes
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • CD BioSciences
    • Charles River Systems, Inc.
简介目录
Product Code: GVR-1-68038-737-7

Structural Biology & Molecular Modeling Techniques Market Growth & Trends:

The global structural biology & molecular modeling techniques market size is expected to reach USD 19.17 billion by 2030, registering to grow at a CAGR of 15.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic diseases, such as diabetes and cancer, which is presumed to propel the market growth during the forecast period.

Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.

The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.

Structural Biology & Molecular Modeling Techniques Market Report Highlights:

  • SaaS & standalone modeling held the largest share of the tools segment in 2023 owing to extensive utilization of computer-assisted structuring and modeling techniques in R&D
  • The drug discovery segment is anticipated to grow at a lucrative CAGR owing to continual introduction of software modifications with focus on enhanced drug designing aimed to accelerate the process in identifying novel therapeutic agents
  • In 2023, North America dominated the global structural biology & molecular modeling techniques market owing to the presence of a wide number of established pharmaceutical companies extensively involved in the commercialization of in silico tools to promote their usage
  • Asia Pacific is expected to grow at an exponential CAGR owing to favorable government initiatives supporting research activities and the increasing trend of outsourcing drug development by the developed economies
  • The key participants are employing clinical and research collaborative strategies promoting the adoption of structural prediction software and databases to gain a competitive advantage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Structural Biology & Molecular Modeling Techniques Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Structural Biology & Molecular Modeling Techniques Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Structural Biology & Molecular Modeling Techniques Market: Tools Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Structural Biology & Molecular Modeling Techniques Market: Tools Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. SaaS & standalone modeling
    • 4.3.1. SaaS & Standalone Modeling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Homology Modeling
      • 4.3.2.1. Homology Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Threading
      • 4.3.3.1. Threading Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Molecular Dynamics
      • 4.3.4.1. Molecular Dynamics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Ab Initio
      • 4.3.5.1. Ab Initio Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Hybrid
      • 4.3.6.1. Hybrid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Visualization & analysis
    • 4.4.1. Visualization & analysis Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Databases
    • 4.5.1. Databases Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Structural Biology & Molecular Modeling Techniques Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Structural Biology & Molecular Modeling Techniques Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Drug Development
    • 5.3.1. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Structural Biology & Molecular Modeling Techniques Market: Regional Estimates & Trend Analysis

  • 6.1. Structural Biology & Molecular Modeling Techniques Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Acellera Therapeutics Inc
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Agilent Technologies, Inc
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Labvantage - Biomax GmbH
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Bruker
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Chemical Computing Group ULC
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Dassault Systemes
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Illumina, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Thermo Fisher Scientific Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. CD BioSciences
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Charles River Systems, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives